Repeat ablative therapy in hereditary or multifocal renal cancer: Functional and oncological outcomes.
CONCLUSION: This study suggests that AT allows to meet the oncological objectives whilst preserving renal function in patients with renal cancer at greater risk of repeated treatments.
PMID: 32778477 [PubMed - as supplied by publisher]
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Gaillard V, Tricard T, Garnon J, Cazzato RL, Dalili D, Gangi A, Lang H Tags: Urol Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Chronic Kidney Disease | Cryotherapy | Epidemiology | Genetics | Kidney Cancer | Nephrectomy | Study | Translocation | Urology & Nephrology